User contributions
From WikiPathways
(Latest | Earliest) View (newer 50) (older 50) (20 | 50 | 100 | 250 | 500)
- 15:43, 23 June 2019 Homo sapiens:Tryptophan metabolism (Replaced secondary ChEBI identifiers with a primary identifiers.)
- 15:37, 23 June 2019 Homo sapiens:Ethanol metabolism production of ROS by CYP2E1 (Replaced a secondary ChEBI identifiers with a primary identifier.)
- 15:37, 23 June 2019 Rattus norvegicus:Ethanol metabolism resulting in production of ROS by CYP2E1 (Replaced a secondary ChEBI identifiers with a primary identifier.)
- 15:33, 23 June 2019 Homo sapiens:Phase I - Functionalization of compounds (Replaced a secondary ChEBI identifiers with a primary identifier.)
- 15:25, 23 June 2019 Saccharomyces cerevisiae:Tryptophan degradation (Replaced secondary ChEBI identifiers with a primary identifiers.)
- 15:23, 23 June 2019 Saccharomyces cerevisiae:Phenylalanine, tyrosine, and tryptophan biosynthesis (Replaced secondary ChEBI identifiers with a primary identifiers.)
- 15:14, 23 June 2019 Homo sapiens:Bile acid and bile salt metabolism (Replaced a secondary ChEBI identifiers with a primary identifier.)
- 14:23, 23 June 2019 Mus musculus:Ethanol metabolism resulting in production of ROS by CYP2E1 (Replaced a secondary ChEBI identifiers with a primary identifier.)
- 08:37, 8 June 2019 Homo sapiens:Measles virus infection (Replaced secondary ChEBI IDs with primary IDs.)
- 07:00, 7 June 2019 Homo sapiens:Aerobic glycolysis - augmented (A few more.)
- 06:57, 7 June 2019 Homo sapiens:Measles virus infection (Replaced a secondary ChEBI ID with primary ID.)
- 06:02, 7 June 2019 Homo sapiens:Aerobic glycolysis - augmented (If there is no identifier, plz leave the Xref fields empty.)
- 05:56, 7 June 2019 Mus musculus: Lipids measured in liver metastasis from breast cancer (Removed the RHEA: prefix from the identifiers.)
- 05:48, 7 June 2019 Homo sapiens:Major receptors targeted by epinephrine and norepinephrine (Removed the RHEA: prefix from the identifier.)
- 05:41, 7 June 2019 Homo sapiens:Metabolism of alpha-linolenic acid (Replaced a secondary ChEBI ID with primary ID.)
- 10:23, 1 June 2019 Mus musculus:Sphingolipid metabolism overview (Removed a unexpected trailing 0.)
- 05:30, 29 May 2019 Homo sapiens:Glycosylation and related congenital defects (Harmonized the OMIM href URL pattern.)
- 05:23, 29 May 2019 Homo sapiens:Gamma-glutamyl cycle for the biosynthesis and degradation of glutathione (Harmonized the OMIM href URL pattern.)
- 18:51, 28 May 2019 WikiPathways SPARQL queries (→WikiPathways with ChEMBL: all molecules targeting pathways)
- 18:39, 28 May 2019 WikiPathways SPARQL queries (→WikiPathways with ChEMBL: all ChEMBL assays for pathways)
- 17:45, 28 May 2019 Homo sapiens:Vitamin B12 disorders (Converted a number of Label-Interaction's to graphical lines.)
- 17:37, 28 May 2019 Homo sapiens:Vitamin B12 disorders (Fixed the href URL.)
- 12:26, 28 May 2019 Homo sapiens:Purine metabolism and related disorders (Converted another interaction to a graphical line.)
- 05:59, 27 May 2019 WP4602 (Discussion edited) (top)
- 05:59, 27 May 2019 N WP4602 (Talkpage autocreated when first thread was posted.)
- 05:59, 27 May 2019 N Rhea identifiers (1) (New page: Hi Chris, we recently learned that Rhea identifiers, unlike their ChEBI counterparts, do not have the "RHEA:" prefix, but are just an integer. I will update this pathway. Can you please up...) (top)
- 06:20, 25 May 2019 Homo sapiens:Major receptors targeted by epinephrine and norepinephrine (Removed broken identifier)
- 06:15, 25 May 2019 Homo sapiens:Major receptors targeted by epinephrine and norepinephrine (Modified title)
- 15:00, 24 May 2019 Homo sapiens:Vitamin B6-dependent and responsive disorders (Removed)
- 18:31, 15 May 2019 Curation:Homology Converted
- 17:05, 15 May 2019 Danio rerio:Acetylcholine synthesis (Replaced a secondary ChEBI ID with primary ID.)
- 05:52, 15 May 2019 Homo sapiens:Metabolism of alpha-linolenic acid (Replaced secondary ChEBI IDs with primary IDs.)
- 12:18, 12 May 2019 Homo sapiens:Alternative pathway of fetal androgen synthesis (Removed the RHEA: prefix from the identifier.)
- 12:05, 12 May 2019 Homo sapiens:Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism (Removed the RHEA: prefix from the identifier.)
- 18:49, 11 May 2019 Homo sapiens:Oxysterols derived from cholesterol (Removed the RHEA: prefix from the identifier.)
- 18:48, 11 May 2019 Homo sapiens:Glycosylation and related congenital defects (Removed the RHEA: prefix from the identifier.)
- 18:45, 11 May 2019 Homo sapiens:Cerebral organic acidurias, including diseases (Removed a copy/paste error.)
- 18:44, 11 May 2019 Homo sapiens:Cerebral organic acidurias, including diseases (Removed the RHEA: prefix from the identifier.)
- 18:23, 11 May 2019 Homo sapiens:Gamma-glutamyl cycle for the biosynthesis and degradation of glutathione (Removed the RHEA: prefix from the identifier.)
- 15:25, 11 May 2019 Homo sapiens:Vitamin D metabolism (Removed the RHEA: prefix from the identifier.)
- 05:37, 9 May 2019 Homo sapiens:Major receptors targeted by epinephrine and norepinephrine (Fixed the type of an metabolite; updated the sec cAMP identifiers to primary ChEBI identifiers.)
- 13:15, 5 May 2019 WormBase/Curation (Species in italics.) (top)
- 07:03, 30 April 2019 Homo sapiens:Blood clotting and drug effects (Replaced secondary ChEBI IDs with primary IDs.)
- 20:29, 28 April 2019 Arabidopsis thaliana:Cytokinin signaling (Added two missing metabolite identifiers.)
- 20:02, 28 April 2019 Homo sapiens:MTHFR deficiency (Added some redundant/empty Biopax content.)
- 06:11, 27 April 2019 Homo sapiens:Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway (Replaced a secondary ChEBI ID with its primary ID.)
- 05:12, 23 April 2019 Mus musculus:Sphingolipid metabolism overview (ID of the class.)
- 16:09, 7 April 2019 Homo sapiens:Ganglio sphingolipid metabolism
- 16:06, 7 April 2019 Homo sapiens:Ganglio sphingolipid metabolism (Added two more identifiers.)
(Latest | Earliest) View (newer 50) (older 50) (20 | 50 | 100 | 250 | 500)
